Search - tctmd.com

Displaying 1 - 20 of 47

Sort: Relevancy | Date

News Daily News

Survey Reveals Troubling Unawareness of Common MI Symptoms

L.A. McKeown

December 19, 2019

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

News Conference News AHA 2019

Swift Angiography in Cardiac Arrest Without STEMI: No 1-Year Survival Benefit

Caitlin E. Cox

November 21, 2019

News Conference News AHA 2019

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

Yael L. Maxwell

November 21, 2019

News Conference News AHA 2019

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

Todd Neale

November 20, 2019

News Conference News AHA 2019

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

Yael L. Maxwell

November 17, 2019

COLCOT Renews Hope for Anti-inflammatory Secondary Prevention

News Conference News AHA 2019

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

Caitlin E. Cox

November 16, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Daily News

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Michael O'Riordan

November 05, 2019

News Daily News

Novel Japanese CTO Algorithm Prompts Potential for a More Global Strategy

Yael L. Maxwell

November 05, 2019

News Daily News

Morphine Not Linked to Increased Short-term Mortality in STEMI: Meta-analysis

L.A. McKeown

November 01, 2019

News Daily News

Sex-Based Nuances Seen in iFR and FFR Testing: DEFINE-FLAIR

Caitlin E. Cox

October 24, 2019

News Daily News

Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe

Yael L. Maxwell

October 16, 2019

News Conference News TCT 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

Todd Neale

October 03, 2019

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

Presentation TCT 2019

FIGARO Registry: Frequency and Reasons for Discordance Between FFR and iFR in Assessment of Lesion Hemodynamic Significance

Presenter: Tomas Kovarnik

September 28, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

News Conference News TCT 2019

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

L.A. McKeown

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

Advertisement

Survey Reveals Troubling Unawareness of Common MI Symptoms

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Swift Angiography in Cardiac Arrest Without STEMI: No 1-Year Survival Benefit

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Novel Japanese CTO Algorithm Prompts Potential for a More Global Strategy

Morphine Not Linked to Increased Short-term Mortality in STEMI: Meta-analysis

Sex-Based Nuances Seen in iFR and FFR Testing: DEFINE-FLAIR

Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

FIGARO Registry: Frequency and Reasons for Discordance Between FFR and iFR in Assessment of Lesion Hemodynamic Significance

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content